Johnson & Johnson, a leading diversified health...
Johnson & Johnson, a leading diversified health care company, reported fourth quarter profits of $378 million, or 59 cents per share, up 12% from 335 million or 52 cents a share a year earlier. Revenue grew 16% to $4.09 billion. For the year, the company said its earnings rose 12% to $2.01 billion, or $3.12 per share, from $1.787 billion or $2.74. Revenue grew 11% to $15.7 billion.
The New Brunswick, N.J.-based company attributed the results to strong sales of its drugs, surgical instruments, contact lenses and a new device called a stent that clears arteries clogged by cholesterol.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
